MorningMed is a community of 814,300 medical professionals

We're a place where medical professionals share news and other news items to help their peers stay up to date

All articles tagged: Type 2 diabetes mellitus without complications (E11.9)

HealthDay 11 July at 04.04 PM

GLP-1 RAs May Reduce Risk for Some Obesity-Linked Cancers Versus Insulin in T2D

For patients with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a reduced risk for 10 of 13 obesity-associated cancers (OACs) compared with insulin, according to a study published online July 5 in JAMA Network Open.Lindsey Wang, from Case Western Reserve University School of Medicine

HealthDay 10 July at 03.18 PM

Delaying Diabetes Progression After Impaired Glucose Improves Long-Term Outcomes

Maintaining several years of nondiabetes status after impaired glucose tolerance (IGT) diagnosis is associated with a significantly lower risk for poor long-term outcomes, according to a study published online July 9 in PLOS Medicine.Xin Qian, from the Chinese Academy of Medical Sciences and Peking Union Medical College in Beiji

HealthDay 09 July at 03.42 PM

Semaglutide Cuts MACE in People With Overweight, Obesity, Regardless of HbA1c

Semaglutide reduces cardiovascular events, regardless of baseline glycated hemoglobin (HbA1c), among people with overweight or obesity and established atherosclerotic cardiovascular disease, according to a study published online June 22 in Diabetes Care.Ildiko Lingvay, M.D., from the University of Texas Southwestern Medical Center in Da

HealthDay 08 July at 09.38 PM

Significantly More Weight Loss Seen With Tirzepatide Versus Semaglutide

Tirzepatide is associated with significantly greater weight loss than semaglutide for adults with overweight or obesity, according to a study published online July 8 in JAMA Internal Medicine.Patricia J. Rodriguez, Ph.D., from Truveta Inc. in Bellevue, Washington, and colleagues compared on-treatment weight loss and rates of gastrointest

HealthDay 08 July at 03.17 PM

ACEi, ARB Use Linked to Lower Risk for Kidney Failure With Replacement Therapy

For individuals with advanced chronic kidney disease (CKD), angiotensin-converting enzyme inhibitor (ACEi) or angiotensin-receptor blocker (ARB) treatment is associated with a reduced risk for kidney failure with replacement therapy (KFRT) but not death, according to a study published online July 2 in the Annals of Internal Medicine.Elai

HealthDay 03 July at 08.32 PM

Semaglutide Linked to Nonarteritic Anterior Ischemic Optic Neuropathy

Semaglutide is associated with nonarteritic anterior ischemic optic neuropathy (NAION) among patients with type 2 diabetes (T2D) and those with overweight/obesity, according to a study published online July 3 in JAMA Ophthalmology.Jimena Tatiana Hathaway, M.D., M.P.H., from the Harvard T.H. Chan School of Public Health in Boston, and

HealthDay 01 July at 05.50 PM

American Diabetes Association, June 21-24

The annual meeting of the American Diabetes Association was held this year from June 21 to 24 in Orlando, Florida, drawing more than 15,000 participants from around the world, including clinicians, academicians, allied health professionals, and others interested in diabetes. The conference highlighted the latest advances in di

HealthDay 01 July at 03.33 PM

Few With Type 2 Diabetes Receive Guideline-Recommended CKD Screening

Fewer than one-quarter of patients with type 2 diabetes (T2D) receive recommended chronic kidney disease (CKD) screening, according to a study published online June 26 in JAMA Network Open.Daniel Edmonston, M.D., from the Duke University School of Medicine in Durham, North Carolina, and colleagues conducted a retrospective cohort study t

HealthDay 28 June at 09.42 PM

Lower Cognitive Function in Adolescence Linked to Stroke Risk

Lower cognitive function in adolescence is associated with increased risk of early-onset stroke, according to a study published online June 27 in the Journal of Epidemiology & Community Health.Aya Bardugo, M.D., from the Hebrew University in Jerusalem, and colleagues examined the association between adolescent cognitive function and

HealthDay 27 June at 03.21 PM

ADA: Bisphenol A Linked to Reduced Peripheral Insulin Sensitivity

Bisphenol A (BPA) administration is associated with reduced peripheral insulin sensitivity among healthy adults, according to a study presented at the annual meeting of the American Diabetes Association, held from June 21 to 24 in Orlando, Florida.Adam Seal, Ph.D., from the California Polytechnic State University in San Luis Obispo, and collea

HealthDay 27 June at 03.18 PM

Exercise + GLP-1 RA Effective for Weight Loss While Preserving BMD

For adults with obesity, without diabetes, combining exercise with the glucagon-like peptide-1 receptor agonist (GLP-1 RA), liraglutide, is effective for weight loss, while preserving bone health, according to a study published online June 25 in JAMA Network Open.Simon Birk Kjær Jensen, Ph.D., from the University of Copenhagen in Denm

HealthDay 27 June at 11.14 AM

Ignorance Could Be Fueling Rising Spread of STDs, Poll Finds

Many sexually transmitted diseases are on the rise in the United States, and a nationwide poll indicates that ignorance about how they're transmitted could be fueling their spread.About a third of Americans (34%) falsely believe sexually transmitted infections (<a href="https://www.healthday.com/a-to-z-health/infectious-diseases/most-common-st

HealthDay 26 June at 03.26 PM

ADA: Tirzepatide Reduces Apnea-Hypopnea Index in Moderate-to-Severe OSA

Tirzepatide reduces the apnea-hypopnea index (AHI) among individuals with moderate-to-severe obstructive sleep apnea and obesity, according to a study published online June 21 in the New England Journal of Medicine to coincide with the annual meeting of the American Diabetes Association, held from June 21 to 24 in Orlando, Florida.At

HealthDay 26 June at 03.25 PM

Dysbiosis in Phylogenetically Diverse Species Associated With Type 2 Diabetes

The gut microbiome has a potential functional role in the pathogenesis of type 2 diabetes (T2D), according to a study published online June 25 in Nature Medicine.Zhendong Mei, Ph.D., from Brigham and Women's Hospital in Boston, and colleagues analyzed 8,117 shotgun metagenomes from 10 cohorts of individuals with T2D, prediabetes, and

HealthDay 25 June at 03.03 PM

Semaglutide Cuts Incidence, Recurrence of Alcohol Use Disorder

Semaglutide may cut incidence and recurrence of alcohol use disorder (AUD) in patients with obesity, according to a study published online May 28 in&nbsp;Nature Communications.William Wang, from Case Western Reserve University in Cleveland, and colleagues used electronic health records of 83,825 patients with obesity to examine associa

HealthDay 25 June at 03.01 PM

Intermittent Fasting Aids Early Diabetes Outcomes More Than Drugs

Intermittent fasting may be a more effective intervention than drugs for people with early diabetes and either obesity or overweight, according to a study published online June 21 in&nbsp;JAMA Network Open.Lixin Guo, M.D., from the Chinese Academy of Medical Sciences in Beijing, and colleagues evaluated the effect of intermittent fasti

HealthDay 21 June at 03.36 PM

Timing of Metformin Important in Metformin-Treated Type 2 Diabetes

Glucose lowering by metformin is greater when given before enteral glucose among patients with type 2 diabetes controlled by metformin monotherapy, according to a study recently published in Diabetologia.Cong Xie, Ph.D., from the University of Adelaide in Australia, and colleagues studied 16 participants with type 2 diabetes that was re

HealthDay 20 June at 03.57 PM

Burden of Chronic Health Conditions Increased for LGTBQ+ Cancer Survivors

Cancer survivors who identify as lesbian, gay, bisexual, transgender, queer, plus (LGBTQ+) have an increased burden of all chronic health conditions, disabilities, and limitations, according to a study published online June 20 in Cancer Epidemiology, Biomarkers &amp; Prevention.Austin R. Waters, from the University of North Carolina a

HealthDay 19 June at 03.43 PM

Benefits of Roux-en-Y Gastric Bypass Sustained in the Long Term

Roux-en-Y gastric bypass (RYGB) is successful in achieving long-term sustained weight loss and diabetes remission, according to a study presented at the annual meeting of the American Society for Metabolic and Bariatric Surgery, held from June 9 to 13 in San Diego.John Nguyen-Lee, M.D., from the Geisinger Medical Center in Danville, Pennsylva

HealthDay 19 June at 12.01 PM

Deadly Strep Bacteria Is Spreading in Japan

A deadly bacterial infection known as streptococcal toxic shock syndrome (STSS) is spreading across Japan, officials in that country report.In March, Japan's National Institute of Infectious Diseases issued its first warning&nbs

HealthDay 18 June at 03.37 PM

Less Than One-Quarter of Patients Hospitalized for CVD Receive Dietary Counseling

Dietary counseling is infrequently documented after hospitalization for cardiovascular disease (CVD) episodes, according to a study recently published in the&nbsp;Journal of the Academy of Nutrition and Dietetics.Eric J. Brandt, M.D., from the University of Michigan in Ann Arbor, and colleagues used data from the Michigan Value Collabo

HealthDay 17 June at 03.37 PM

Bariatric Surgery Cuts Conversion to Diabetes Over Long-Term Follow-Up

Bariatric surgery significantly decreases the conversion from prediabetes to type 2 diabetes, according to a study presented at the annual meeting of the American Society for Metabolic and Bariatric Surgery, held from June 9 to 13 in San Diego.John Nguyen-Lee, M.D., from the Geisinger Medical Center in Danville, Pennsylvania, and colleagues eval

HealthDay 13 June at 04.10 PM

GLP-1 RA Use Linked to Lower Quality of Bowel Preparation

The use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for diabetes or obesity is associated with a lower quality of bowel preparation among patients undergoing colonoscopy, according to a study published online in the June issue of the American Journal of Gastroenterology.Rebecca Yao, M.D., M.P.H., from the Mayo Clinic in R

Evalytics 13 May at 08.50 PM

1 in 8 adults in the US has taken Ozempic or another GLP-1 drug, KFF survey finds

The article discusses a survey showing the rise in popularity of Ozempic, a GLP-1 drug, for type 2 diabetes. It highlights the drug's effectiveness and patient satisfaction, leading to increased prescriptions. However, concerns remain about its cost and accessibility for some patients.

Evalytics 19 March at 06.08 AM

FDA approves first drug for common form of liver inflammation

The FDA has approved the first-ever medication for nonalcoholic steatohepatitis (NASH), a common form of liver inflammation linked to obesity, type 2 diabetes, and other metabolic conditions. NASH, characterized by liver inflammation due to excess fat accumulation, affects an estimated 6 to 8 million people in the US with moderate to advanced fibrosis.

Evalytics 04 March at 06.12 PM

Eating Smart in a Processed World: The Truth About Ultra-Processed Foods

The BMJ study by Lane MM et al. warns of health risks from ultra-processed foods like obesity and heart disease due to their poor nutrition. Global trends call for stricter regulations and healthier options. Both individuals and the food industry must act to promote healthier eating habits.

Evalytics 04 March at 05.59 PM

Does yogurt reduce risk of diabetes? The FDA says it might.

The FDA approves a claim linking yogurt consumption to reduced risk of type 2 diabetes, backed by scientific evidence. However, it underscores the importance of incorporating yogurt into a balanced diet and lifestyle for maximum health benefits.

Evalytics 29 January at 05.19 PM

Why one particular diet is found to be the best year after year

The Mediterranean diet is praised for its health benefits, reducing heart disease and promoting longevity. It emphasizes fresh fruits, vegetables, olive oil, and fish while limiting red meat and processed foods. Studies suggest it's an effective way to improve overall health.

HealthDay 26 January at 10.07 PM

Coronary Artery Disease Testing After Initial Heart Failure Hospitalization Aids Outcomes

Coronary artery disease (CAD) testing within 90 days of hospitalization for heart failure is associated with a lower risk for heart failure readmission or all-cause mortality, according to a study published online Jan. 18 in the&nbsp;Journal of General Internal Medicine.Cheng‑Wei Huang, M.D., from Kaiser Permanente Los Angeles Medical C

HealthDay 23 January at 04.10 PM

Risks for Diabetes, CVD Up in Acute, Postacute COVID-19 Phases

The risks for diabetes mellitus (DM) and cardiovascular disease (CVD) are increased in the acute and postacute COVID-19 phases, according to a study published online July 19 in PLOS Medicine.Emma Rezel-Potts, Ph.D., from King's College London, and colleagues conducted a cohort study from 2020 to 2021 analyzing electronic records for

HealthDay 22 January at 04.59 PM

Healthful Plant-Based Diet May Lower Risk for Type 2 Diabetes

A healthful plant-based diet may lower the risk for type 2 diabetes mellitus (T2DM), according to a study published in the January issue of Diabetes &amp; Metabolism.Alysha S. Thompson, from Queen's University Belfast in Northern Ireland, and colleagues examined associations between healthful and unhealthful plant-based diet indices (hP

HealthDay 17 January at 04.28 PM

Bariatric Surgery Tied to Slower Cognitive Decline in People With Obesity

Bariatric surgery may slow cognitive decline for people with obesity, according to a study published online Dec. 5 in the&nbsp;Journal of Nutrition, Health &amp; Aging.Evan L. Reynolds, Ph.D., from the University of Michigan in Ann Arbor, and colleagues examined the effect of surgical weight loss on cognition in individuals with clas

HealthDay 05 January at 10.20 PM

FDA Allows Florida to Import Cheaper Drugs From Canada

In what could prove to be a major turning point for the prescription drug market in the&nbsp;United States, the U.S. Food and Drug Administration has approved a Florida plan to import drugs from Canada.U.S. residents can now buy directly from Canadian pharmacies out of their own pockets, but state Medicaid programs have not been allowed to purcha

HealthDay 31 December at 04.59 AM

Catheter Ablation for Atrial Fibrillation Cuts Risk for Dementia, Death

In patients with atrial fibrillation (AF), those undergoing catheter ablation have a lower risk for incident dementia and mortality, according to a study published online Aug. 23 in the Journal of the American Geriatrics Society.Stephanie L. Harrison, Ph.D., from the University of Liverpool in the United Kingdom, and colleagues examined

HealthDay 29 December at 04.45 PM

High Levels of HDL Cholesterol Tied to Higher Dementia Risk

Elevated levels of high-density lipoprotein cholesterol (HDL-C) are associated with an increased risk for all-cause dementia, according to a study published online Nov. 29 in&nbsp;The Lancet Regional Health: Western Pacific.Sultana Monira Hussain, M.B.B.S., M.P.H., Ph.D., from Monash University in Melbourne, Australia, and colleagues co

HealthDay 28 December at 11.47 PM

Modifiable Risk Factors Tied to Young-Onset Dementia

Several modifiable factors are associated with a higher risk for young-onset dementia (YOD), according to a study published online Dec. 26 in&nbsp;JAMA Neurology.Stevie Hendriks, Ph.D., from Maastricht University in the Netherlands, and colleagues examined 39 factors associated with the incidence of YOD from the literature using data

HealthDay 26 December at 05.03 PM

KMgCit Superior to KCl for Preventing Thiazide-Induced Hyperglycemia

For patients with hypertension without diabetes, potassium magnesium citrate (KMgCit) is better than potassium chloride (KCl) for preventing thiazide diuretic (TD)-induced hyperglycemia, according to a study published in the December issue of Hypertension.Noting that TDs, which are the first-line treatment for hypertension, can cause e

HealthDay 20 December at 05.12 PM

ED Visit Rate 72.2 Per 1,000 Adults With Diabetes in 2020 to 2021

In 2020 to 2021, the emergency department visit rate was 72.2 visits per 1,000 adults with diabetes, with the rate increasing with age, according to a December data brief published by the U.S. Centers for Disease Control and Prevention National Center for Health Statistics.Loredana Santo, M.D., M.P.H., from the National Center for Health Stat

HealthDay 13 December at 10.08 PM

New Poll Finds Older Americans Believe Medicare Should Cover Weight-Loss Drugs

According to the latest University of Michigan National Poll on Healthy Aging, about three in four older Americans (76 percent) believe Medicare should cover the cost of weight-loss medications like Ozempic, Wegovy, or Zepbound.More than four out of five older adults (83 percent) think insurance companies should pay for drugs that help people

HealthDay 13 December at 03.42 PM

Perfluorooctanesulfonic Acid Exposure Linked to Lower Bone Density

In a cohort of Hispanic adolescents and young adults, plasma perfluorooctanesulfonic acid (PFOS) exposure is associated with lower bone mineral density (BMD), according to a study published online Dec. 6 in Environmental Research.Emily Beglarian, M.P.H., from the Keck School of Medicine at the University of Southern California in Los

HealthDay 11 December at 11.55 PM

High BMI in Adolescence Linked to Early CKD in Young Adulthood

High body mass index (BMI) in late adolescence is associated with early chronic kidney disease (CKD) in young adulthood, according to a study published online Dec. 11 in JAMA Pediatrics.Avishai M. Tsur, M.D., from the Israel Defense Forces, Medical Corps, in Ramat Gan, and colleagues examined the association between adolescent BMI and e

Evalytics 11 December at 03.07 PM

New cause of diabetes discovered, offering potential target for new classes of drugs to treat the disease

The article discusses recent research on diabetes, indicating that there may be potential for new drug classes to treat the disease. Scientists are exploring innovative approaches to target different aspects of diabetes, potentially leading to more effective treatments in the future.

HealthDay 07 December at 04.41 PM

Slow-to-Moderate Weight Loss Linked to Lower Mortality in Knee, Hip OA

For individuals with overweight or obesity and knee or hip osteoarthritis (OA), a slow-to-moderate, but not a fast, rate of weight loss is associated with a reduced risk for all-cause mortality, according to a study published online Dec. 6 in Arthritis &amp; Rheumatology.Jie Wei, Ph.D., from Xiangya Hospital in Changsha, China, and col

HealthDay 01 December at 04.56 PM

High Systolic BP Tied to Higher Cardiovascular Mortality in T2DM

Clinic systolic blood pressure (BP) ≥130 mm Hg or diastolic BP levels ≥90 mm Hg are associated with a higher risk for cardiovascular disease (CVD) mortality in people with type 2 diabetes mellitus (T2DM), according to a study published online Nov. 28 in the&nbsp;Journal of the American Heart Association.Loraine Liping Seng, Ph.D., from t

HealthDay 29 November at 04.42 PM

Walking at Faster Speeds Linked to Reduction in Risk for Type 2 Diabetes

Walking at faster speeds seems to be associated with a reduction in the risk for type 2 diabetes, according to a review published online Nov. 28 in the British Journal of Sports Medicine.Ahmad Jayedi, Ph.D., from the University of Medical Sciences in Semnan, Iran, and colleagues examined the association between walking speed and the

HealthDay 28 November at 04.38 PM

Study IDs Barriers to Eye Screening Among Adults With Diabetes

Food insecurity, housing insecurity, mental health concerns, and the perceived importance of practitioner concordance are associated with a lower likelihood of receiving eye care among adults with diabetes, according to a study published online Nov. 16 in&nbsp;JAMA Ophthalmology.Rohith Ravindranath, from Stanford University in Palo Alt

HealthDay 27 November at 04.51 PM

American Heart Association, Nov. 11-13

The annual meeting of the American Heart Association was held this year from Nov. 11 to 13 in Philadelphia and attracted participants from around the world, including cardiovascular specialists, surgeons, and nurses as well as other health care professionals. The conference featured presentations focusing on the lates

HealthDay 22 November at 04.33 PM

Mean Platelet Volume Linked to Mortality in Peritoneal Dialysis Patients

For patients treated with peritoneal dialysis (PD), mean platelet volume (MPV) is associated with all-cause mortality and cardiovascular mortality, according to a study published online Nov. 8 in BMC Cardiovascular Disorders.Jianghai Wang, from the Dongying People's Hospital in China, and colleagues estimated the relationship between

HealthDay 14 November at 11.43 PM

American Society of Nephrology, Nov 2-5

The annual meeting of the American Society of Nephrology (Kidney Week) was held this year from Nov. 2 to 5 in Philadelphia and attracted participants from around the world, including nephrology specialists, researchers, scientists, and other health care professionals. The conference featured presentations focusing on the latest adv

HealthDay 09 November at 04.08 PM

FDA Approves New Diet Drug Zepbound, a Version of the Diabetes Med Mounjaro

A second injectable diabetes drug has been approved for weight loss in overweight and obese adults, the U.S. Food and Drug Administration announced Wednesday. The weight-loss drug Zepbound contains the same active ingredient, tirzepatide, as the diabetes drug Mounjaro.Zepbound works by activating hormone receptors in the body to reduce appetite

Evalytics 06 November at 03.44 PM

Another Study Ties Statins to T2D: Should Practice Change?

A recent study from the LODESTAR trial suggests a modestly increased risk of type 2 diabetes with statin use, particularly with rosuvastatin over atorvastatin. Despite this, the cardiovascular benefits of statins are deemed to outweigh the diabetes risk, with experts advocating for their continued use while calling for more research into managing the associated diabetes risk.